Top Markets
Coin of the day
PLx Pharma Inc. PLx Pharma Inc.

PLx Pharma Inc.

PLXP
株式のランク #41013
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
株価
$0.00575
最終同期: 2023-05-23
時価総額
$51.30K
変化(1日)
-17.86%
変化(1年)
0.00%
US
取引 PLx Pharma Inc. (PLXP)

カテゴリー

PLx Pharma Inc.(PLXP)の利益
2026 時点の利益 TTM: 0
PLx Pharma Inc. の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
PLx Pharma Inc. の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。